tradingkey.logo

Privia Health Group Inc

PRVA
21.990USD
+0.480+2.23%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
2.70BMarktkapitalisierung
146.93KGV TTM

Privia Health Group Inc

21.990
+0.480+2.23%

mehr Informationen über Privia Health Group Inc Unternehmen

Privia Health Group, Inc. is a technology-driven, national physician-enablement company. The Company collaborates with medical groups, health plans and health systems. It enhances physician practices, improves patient experiences and doctors for delivering care in both in-person and virtual care settings. Its Privia Platform is powered by the Privia Technology Solution, an end-to-end, cloud-based technology solution that integrates both Privia-developed and third-party applications into an interface and workflow that manages all aspects of its Privia Providers provision of healthcare services. Privia Platform optimizes provider workflow across the full continuum of reimbursement arrangements. The Company provides management services to each Medical Group though a local management services organization, which provides Medical Groups with access to value-based care (VBC) opportunities either directly or through Privia-owned accountable care organizations.

Privia Health Group Inc Informationen

BörsenkürzelPRVA
Name des UnternehmensPrivia Health Group Inc
IPO-datumApr 29, 2021
CEOMehrotra (Parth)
Anzahl der mitarbeiter1140
WertpapierartOrdinary Share
GeschäftsjahresendeApr 29
Addresse950 N. Glebe Rd., Suite 700
StadtARLINGTON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl22203
Telefon15713668850
Websitehttps://www.priviahealth.com/
BörsenkürzelPRVA
IPO-datumApr 29, 2021
CEOMehrotra (Parth)

Führungskräfte von Privia Health Group Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
1.33M
+8396.00%
Mr. David Mountcastle, CPA
Mr. David Mountcastle, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
301.84K
--
Mr. Parth Mehrotra
Mr. Parth Mehrotra
Chief Executive Officer, Director
Chief Executive Officer, Director
267.95K
-47047.00%
Dr. Patricia Anne Maryland
Dr. Patricia Anne Maryland
Independent Director
Independent Director
31.19K
+8396.00%
Dr. Jaewon Ryu, M.D.
Dr. Jaewon Ryu, M.D.
Independent Director
Independent Director
27.52K
+8396.00%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Independent Director
Independent Director
7.67K
+7668.00%
Mr. Shawn Morris, CPA
Mr. Shawn Morris, CPA
Director
Director
--
--
Ms. Nancy G. Cocozza
Ms. Nancy G. Cocozza
Independent Director
Independent Director
--
--
Mr. David King
Mr. David King
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Thomas A. (Tom) Mccarthy
Mr. Thomas A. (Tom) Mccarthy
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
1.33M
+8396.00%
Mr. David Mountcastle, CPA
Mr. David Mountcastle, CPA
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
301.84K
--
Mr. Parth Mehrotra
Mr. Parth Mehrotra
Chief Executive Officer, Director
Chief Executive Officer, Director
267.95K
-47047.00%
Dr. Patricia Anne Maryland
Dr. Patricia Anne Maryland
Independent Director
Independent Director
31.19K
+8396.00%
Dr. Jaewon Ryu, M.D.
Dr. Jaewon Ryu, M.D.
Independent Director
Independent Director
27.52K
+8396.00%
Mr. Lance V. Berberian
Mr. Lance V. Berberian
Independent Director
Independent Director
7.67K
+7668.00%

Umsatzaufteilung

Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
FFS-patient care
352.60M
60.75%
Capitated revenue
90.91M
15.66%
Shared savings
79.99M
13.78%
FFS-administrative services
33.62M
5.79%
Care management fees
20.99M
3.62%
Other revenue
2.31M
0.40%
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
FFS-patient care
352.60M
60.75%
Capitated revenue
90.91M
15.66%
Shared savings
79.99M
13.78%
FFS-administrative services
33.62M
5.79%
Care management fees
20.99M
3.62%
Other revenue
2.31M
0.40%

Aktionärsstatistik

Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.35%
The Vanguard Group, Inc.
9.73%
Durable Capital Partners LP
9.51%
Fidelity Management & Research Company LLC
8.94%
Rubicon Founders, LLC
4.69%
Andere
53.77%
Aktionäre
Aktionäre
Anteil
BlackRock Institutional Trust Company, N.A.
13.35%
The Vanguard Group, Inc.
9.73%
Durable Capital Partners LP
9.51%
Fidelity Management & Research Company LLC
8.94%
Rubicon Founders, LLC
4.69%
Andere
53.77%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
60.11%
Investment Advisor/Hedge Fund
20.42%
Hedge Fund
14.53%
Individual Investor
6.65%
Research Firm
1.66%
Pension Fund
1.42%
Bank and Trust
0.37%
Sovereign Wealth Fund
0.05%
Insurance Company
0.03%

Institutionelle Beteiligung

Aktualisiert: Thu, Jan 1
Aktualisiert: Thu, Jan 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
531
121.22M
98.55%
-6.01M
2025Q3
514
121.30M
98.62%
-7.52M
2025Q2
517
129.73M
106.38%
-7.98M
2025Q1
530
136.71M
112.18%
-7.58M
2024Q4
523
135.99M
112.85%
-22.61M
2024Q3
533
137.04M
114.53%
-19.89M
2024Q2
535
137.24M
115.06%
-22.76M
2024Q1
525
138.01M
116.30%
-17.09M
2023Q4
500
129.42M
109.89%
-22.91M
2023Q3
486
123.27M
105.26%
-25.19M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
BlackRock Institutional Trust Company, N.A.
16.43M
13.35%
+751.31K
+4.79%
Sep 30, 2025
The Vanguard Group, Inc.
12.08M
9.82%
+607.45K
+5.30%
Sep 30, 2025
Durable Capital Partners LP
11.69M
9.51%
+203.84K
+1.77%
Sep 30, 2025
Fidelity Management & Research Company LLC
11.00M
8.94%
-1.24M
-10.13%
Sep 30, 2025
Rubicon Founders, LLC
5.77M
4.69%
--
--
Sep 30, 2025
Boehler (Adam)
5.77M
4.69%
-505.00K
-8.04%
Oct 20, 2025
Riverbridge Partners, LLC
4.63M
3.77%
-314.00K
-6.35%
Sep 30, 2025
State Street Investment Management (US)
4.35M
3.54%
+182.15K
+4.37%
Sep 30, 2025
Van Berkom & Associates Inc.
3.77M
3.07%
+873.34K
+30.10%
Sep 30, 2025
Principal Global Investors (Equity)
2.74M
2.23%
-60.42K
-2.15%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
Innovator IBD Breakout Opportunities ETF
2.68%
Global X HealthTech ETF
2.53%
State Street SPDR S&P Health Care Services ETF
2.19%
Invesco S&P SmallCap Health Care ETF
1.72%
First Trust Nasdaq Lux Digi Health Solutions ETF
1%
Langar Global HealthTech ETF
0.78%
Harbor Human Capital Factor US Small Cap ETF
0.63%
First Trust Small Cap Growth AlphaDEX Fund
0.57%
iShares U.S. Healthcare Providers ETF
0.44%
WisdomTree US SmallCap Quality Growth Fund
0.35%
Mehr Anzeigen
Innovator IBD Breakout Opportunities ETF
Anteil2.68%
Global X HealthTech ETF
Anteil2.53%
State Street SPDR S&P Health Care Services ETF
Anteil2.19%
Invesco S&P SmallCap Health Care ETF
Anteil1.72%
First Trust Nasdaq Lux Digi Health Solutions ETF
Anteil1%
Langar Global HealthTech ETF
Anteil0.78%
Harbor Human Capital Factor US Small Cap ETF
Anteil0.63%
First Trust Small Cap Growth AlphaDEX Fund
Anteil0.57%
iShares U.S. Healthcare Providers ETF
Anteil0.44%
WisdomTree US SmallCap Quality Growth Fund
Anteil0.35%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI